About Nuuron

Nuuron was founded by Fabian Queisner and Dr. Markus Müschenich. The scientific director is Priv.-Doz. Dr. Julian Keil. The Nuuron team consists of experts in the fields of neuroscience, medicine, neuroinformatics, machine learning and public health.

Press releases

Press
31. October 2024

Berlin-Based Neurotech Startup Nuuron Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease

Activating the Memory System of the Brain with Software to Treat Alzheimer’s DiseaseNuuron is developing a fully digital Alzheimer’s therapy based on a proprietary neuromodulation technology. Nuuron’s algorithms produce ultra-high frequency, digital-photonic stimuli that activate the Memory System of Alzheimer’s patients, aiming to improve memory formation and memory recall. This digital disease-modifying therapy uses the retina as interface into the brain and employs advanced VR and
 

Info & Contact

Address

Nuuron GmbH
c/o Mindspace, Friedrichstrasse 68, 10117 Berlin

In portfolio

21. Oct 2024
 

Tilmann Petersen

Investment Manager